Home / Healthcare / Pulmonary Arterial Hypertension Treatment Market
Pulmonary Arterial Hypertension (PAH) Treatment Market Size, Share and Analysis by Drug Class (Soluble Guanylate Cyclase (SGC) Stimulators,Prostacyclin and Prostacyclin Analogs, Phosphodiesterase 5 (PDE-5), Endothelin Receptor Antagonists (ERA)), By End User (Hospitals, Clinics, Others), and Regional Forecast, 2025-2032
Report Format: PDF | Published Date: Ongoing | Report ID: FBI101003 | Status : UpcomingSummary
TOC
- Global
- 2023
- 2019-2022